Engflag

Acton OR

Quick links to important sections

Acton OR

Acton OR_EN

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acton OR

Property Description
Active ingredient Paracetamol (Acetaminophen)
Form Modified-release oral tablet
Pharmacological class Analgesic and Antipyretic
Common use Relief of pain and fever
Origin Synthetic para-aminophenol derivative

Identity and Chemical Classification

Acton OR is a specific pharmacotherapeutic agent whose active ingredient is Paracetamol, known internationally as Acetaminophen (APAP). This compound is synthetic and belongs to the para-aminophenol class, which is widely recognized in clinical settings for its efficacy in managing discomfort. It is classified as both an Analgesic (pain reliever) and an Antipyretic (fever reducer), placing it within the category of Non-Opioid Analgesics. This formulation is commonly available with Over-the-Counter (OTC) status for managing general symptoms, primarily targeting adults and adolescents.

The Specific Form: Modified-Release Paracetamol Tablets

The formulation Acton OR is supplied as an oral tablet that is engineered as a modified-release or sustained-release preparation. This specialized dosage form is achieved through a solid matrix that controls the rate at which the active compound, Paracetamol, is released into the body following the oral route of administration. Modified-release formulations are designed to offer a prolonged therapeutic effect. This specific design is integral to the product’s function, aiming to provide continuous relief over a longer period compared to standard, immediate-release tablets.

General Purpose: Pain and Fever Symptom Relief

The fundamental general purpose of Acton OR is to address the common symptoms of discomfort and elevated body temperature. Due to its classification as an Analgesic and Antipyretic, its primary effects are pain relief and fever reduction. Its action centrally modulates the body's perception of pain and assists in resetting the temperature-regulating center, thereby providing broad, reliable symptomatic relief for common ailments like the aches and pains often experienced during a cold or influenza.

What side effects are possible with Acton OR?

The information below is based strictly on the regulatory safety classifications and adverse reaction data documented by governmental health authorities, such as the FDA and EMA-affiliated national agencies.

Adverse Reaction Scope

Classification Category Documented Effects Frequency System-Organ Class
Hepatobiliary Hepatic necrosis, acute liver failure Serious (Dose-Related) Hepatobiliary Disorders
Skin Severe Cutaneous Adverse Reactions (SCARs), rash, pruritus Very Rare to Rare Skin and Subcutaneous Tissue Disorders
Blood Thrombocytopenia, agranulocytosis, pancytopenia Rare to Not Known Blood and Lymphatic Disorders

Most adverse reactions are categorized as Rare or of Frequency Not Known when the active ingredient, Paracetamol (Acetaminophen), is used within therapeutic guidelines. The most serious safety concern documented across regulatory labels is the risk of severe liver damage and acute liver failure, which is predominantly associated with overdose or use exceeding daily limits.

Population-Specific Safety Considerations

Use is contraindicated in patients with severe hepatic impairment or severe active liver disease. Caution is advised for individuals with severe renal impairment, as longer dosing intervals may be warranted. The risk of liver toxicity is increased in patients with chronic alcoholism, chronic malnutrition, or conditions leading to glutathione depletion.

Safety-Related Restrictions

To prevent accidental overdose, official safety documentation strictly advises against concomitant use of Acton OR with any other product containing Paracetamol or Acetaminophen. Furthermore, prolonged regular use may enhance the effect of oral anticoagulants, such as warfarin, which increases the documented risk of bleeding.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Acton OR (Paracetamol) carries the officially documented risk of Acute Liver Failure (Hepatotoxicity), which is potentially fatal and may necessitate a liver transplant. Initial manifestations like Nausea, Vomiting, and Anorexia may be mild or absent. However, severe outcomes such as Jaundice, Encephalopathy, and Coagulopathy are typically delayed, often appearing 24 to 48 hours after ingestion.

Immediate Medical Attention is Required in all cases of suspected overdose, irrespective of the patient's current symptomatic state. Regulatory documents mandate immediate transfer to a hospital for assessment and contact with a national Poison Centre. This action is critical because effective intervention against the life-threatening hepatic injury is time-dependent.

The specific antidote, N-acetylcysteine (NAC), is documented in the official labeling. Given the modified-release nature of the formulation, its absorption is often prolonged and unpredictable. This characteristic mandates extended hospital monitoring, repeat testing of plasma paracetamol concentrations, and careful monitoring of Liver Function Tests (LFTs) and INR to guide treatment duration. Individuals with underlying liver disease or conditions leading to glutathione depletion are officially noted to have an increased risk of severe toxicity.

Therapeutic Uses of Acton OR

What Acton OR Treats: Main Uses and Benefits

The core purpose of Acton OR, a paracetamol-based formulation, is applied in addressing symptoms related to physical discomfort and systemic imbalance. Its primary uses are for managing pain and reducing fever.

Symptom Management and Therapeutic Scope

Acton OR is generally used across conditions characterized by periods of heightened symptoms by providing sustained management of mild to moderate pain. This sustained-release formulation is relevant for easing discomfort associated with musculoskeletal pain, the stiffness of osteoarthritis, and acute episodes like headaches, dental pain, or menstrual pain. It also plays a role in managing symptoms related to systemic illness by helping to reduce fever and alleviate generalized body aches.

“The medication is applied in scenarios where additional management of discomfort is required during episodes marked by heightened symptoms.”

This supportive benefit provides support that helps ease the overall symptom load of ongoing discomfort, and may assist with maintaining functional stability during symptomatic phases.

Quick Fact: Relief for Persistent Discomfort
The modified-release design is relevant for managing symptoms that create noticeable physiological strain, particularly recurrent or chronic pain states, by supporting sustained symptom management over longer periods.

Regulatory References

  1. NIH MedlinePlus Drug Information on Acetaminophen

Eligibility and Restrictions for Use

The eligibility for Acton OR (Modified-Release Paracetamol) is strictly governed by regulatory documentation that defines which populations can use the medicine and which are restricted or contraindicated. The approved population consists of adults and adolescents (generally 12 years of age and older) who do not possess any absolute contraindications. Use in younger children is not established for this specific modified-release formulation.

Category Official Eligibility Rule
Absolute Contraindications Use is strictly forbidden for individuals with a known hypersensitivity to paracetamol or any excipient, or those diagnosed with severe active liver disease or severe hepatic impairment.
Age Restriction This modified-release formulation is generally not recommended or contraindicated for children under 12 years of age based on regulatory findings.
Conditional Use Use requires special caution and medical guidance in populations with severe renal impairment, severe malnutrition, or a history of chronic heavy alcohol consumption.
Pregnancy/Lactation Use during pregnancy is permitted but requires caution at the lowest effective dose for the shortest duration. The medication is generally considered compatible during breastfeeding.

What should I know about interactions with other medicines?

The interaction profile for Acton OR (Paracetamol) is strictly defined by pharmacokinetic clearance changes and augmented toxicity risks, as documented in official regulatory sources. A formal restriction prohibits co-administration with any other medicinal product containing acetaminophen or paracetamol to avoid overdose and severe liver damage.

Specific medicines officially alter paracetamol clearance. Probenecid, by inhibiting conjugation, reduces clearance, leading to increased plasma exposure and necessitating a regulatory restriction on the amount administered. Conversely, enzyme-inducing agents like Phenytoin, Carbamazepine, and Rifampicin accelerate paracetamol metabolism, which increases the formation of toxic metabolites and raises the risk of hepatotoxicity. Chronic, excessive alcohol use carries the same documented risk.

Pharmacodynamic interactions include the potential enhancement of the anticoagulant effect of Warfarin and other coumarins with prolonged use, which requires regular monitoring. The combination with Zidovudine carries an increased official risk of neutropenia. Furthermore, Flucloxacillin co-administration has been officially associated with reports of High Anion Gap Metabolic Acidosis in patients with certain risk factors.

Timing-based rules apply to Cholestyramine, which reduces absorption and must be separated from Acton OR administration by at least one hour. These official constraints highlight specific risks that are greater in populations with pre-existing hepatic impairment or chronic alcoholism.

Mechanism of Action

How Acton OR Works

Acton OR functions by exerting a targeted influence on core molecular and physiological processes, specifically engaging mechanisms that modulate dysregulated states.

Targeted Receptor/Enzyme Modulation

This mechanism involves the drug's initial action on a defined biological target, such as a specific receptor subtype or regulatory enzyme. By acting as a highly selective agonist or antagonist, Acton OR initiates or suppresses the first molecular event of a signaling sequence. This targeted activity influences the overall amplitude of the cellular response.

Downstream Signaling Cascade Adjustment

Following the initial binding event, Acton OR modulates the subsequent molecular cascades and signal transduction pathways. It alters the activity of secondary messengers or regulatory proteins, modulating signaling dynamics in pathways exhibiting heightened activity. This action is relevant in pathways where rapid signal propagation occurs.

Influence on Physiological Regulation

The culmination of these effects results in an adjustment of activity within the targeted pathways. By influencing the dynamic activity of key neural or humoral pathways, Acton OR's action influences the regulation of processes exhibiting heightened physiological activity. This leads to a mechanistic adjustment in systemic activity, which shapes the drug's overall effect profile.

Dosage and Administration Information

How to Use Acton OR (Risedronate): Official Administration Guidelines

Acton OR (Risedronate) is an oral bisphosphonate. Proper administration is essential to ensure efficacy and minimize local adverse effects.

Administration Requirements

Requirement Official Instruction
Route of Administration Oral tablet.
Timing Relative to Meals Take at least 30 minutes before the first food, drink (other than plain water), or any other oral medication of the day.
Liquid and Preparation Swallow the tablet whole with a full glass of plain water (6 to 8 ounces). Do not use mineral water, coffee, tea, juice, or milk. The tablet must not be chewed, crushed, or broken.
Posture Swallow while in an upright position (sitting or standing).
Post-Dose Activity Do not lie down for at least 30 minutes after taking the tablet.

Dosing Schedules

Acton OR is available in various strengths corresponding to different official dosing frequencies:

  • Daily: 5 mg or 30 mg.
  • Weekly: 35 mg.
  • Monthly: 150 mg or 75 mg (taken on two consecutive days each month).

Missed Dose Instructions

If a weekly or monthly dose is missed, it should be taken the morning after it is remembered, provided the next regularly scheduled dose is more than 7 days away. If the next dose is due within 7 days, the missed dose should be skipped, and the original schedule resumed.

Note on Population-Specific Use: Use is generally not recommended in patients with severe renal impairment (creatinine clearance <30 mL/min).

Recent Clinical Evidence

Acton OR: Recent Clinical Evidence

Evidence for Use in Osteoarthritis Pain

Research exploring the specific application of modified-release paracetamol, the active component of Acton OR, was studied in research contexts involving recurrent musculoskeletal discomfort and Osteoarthritis (OA). Randomized Controlled Trials (RCTs) involving adults with symptomatic OA monitored changes in pain intensity and functional capacity. Findings reported that the difference in outcomes measured when compared to control substances was consistently reported as minimal or not clinically important. High-quality comparative data exploring whether there is a difference in duration of effect when compared against the standard immediate-release formulation across all populations with chronic pain, is limited.

Evidence for Use in Acute Pain and Fever

The research base for the compound's application in research contexts involving outcomes related to physical discomfort and systemic or functional imbalance is substantial. Studies, often single-dose RCTs, monitor patient-reported outcomes describing perceived discomfort and changes in symptom intensity over short intervals. The core existing evidence describing outcomes related to patient-reported symptoms is primarily derived from studies of the Immediate-Release (IR) paracetamol formulation. Comparative trials are needed to explore whether a prolonged duration of action is observed with the modified-release formulation across the full range of acute pain types.

Low Back Pain and Research Gaps

The compound was studied for its application in research contexts including non-specific Low Back Pain (LBP). High-quality Systematic Reviews and RCTs reported that the measured outcomes for pain and functional status were not significantly different from the measurements observed in the inactive control groups. This highlights a significant gap in the utility of the evidence for this specific condition. Furthermore, the clinical trials used for the assessment of Acton OR typically use short-term observation periods, meaning that long-term outcomes beyond these immediate treatment periods are not well characterized in controlled trial settings. Data for certain subgroups, such as older adults and those with comorbidities, remain insufficient.

Key Studies & References Acetaminophen Drug Information

Frequently Asked Questions (FAQ)

Common questions about Acton OR (FAQ)

Q: How should I take this medication? (e.g., with or without food, time of day)

Official regulatory documents indicate that Acton OR can be taken by mouth with or without food. The precise timing and frequency of taking the medication are determined by the prescribing healthcare professional.

Q: Can I drink alcohol while taking this medication?

Regulatory safety information indicates that consuming alcohol while taking Acton OR is typically not recommended. Combining alcohol with this medication may increase certain central nervous system side effects, including sleepiness, dizziness, and difficulty concentrating.

Q: Does this medication require any dose adjustment for elderly patients?

According to official product information, a specific dose adjustment based on age alone is not usually needed for elderly patients. However, dosing considerations for Acton OR are required for all adult patients with impaired or reduced renal (kidney) function, according to official labeling.

How should Acton OR be stored and disposed of?

How to Store and Dispose of Acton OR

Official Storage Requirements

Acton OR (modified-release paracetamol tablets) must be stored at room temperature, generally defined as 20°C to 25°C (68°F to 77°F). It must be kept in the original container with the cap tightly closed to protect the integrity of the tablet from light and excess moisture, which means avoiding storage in the bathroom or near sources of excess heat.

Child-Safety and Stability

The medication must be kept strictly out of the sight and reach of children and safety caps must be locked. To maintain stability, the modified-release tablet should not be crushed or chewed.

Disposal Instructions

Unused or expired Acton OR should be disposed of through a drug take-back program. If a program is unavailable, it may be mixed with an unpalatable substance (like dirt or coffee grounds) in a sealed bag and placed in household trash, in accordance with local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acton OR found in:

A-Z Index: